Moody’s affirms ‘Baa1’ rating on Central Washington Hospital

Moody’s Investors Service affirmed its “Baa1” rating on Wenatchee-based Central Washington Hospital’s revenue bonds, affecting $113 million of debt.

Advertisement

The affirmation is a result of several factors, including the hospital’s solid operating performance, improved liquidity and healthy market position. Moody’s unfavorably viewed the hospital’s weaker balance sheet, high debt metrics and a challenging service area.

The outlook is stable, reflecting Moody’s expectation that performance measures will remain solid as balance sheet and debt metrics improve.

More articles on healthcare finance:
13 latest hospital credit rating downgrades
14 recent hospital, health system outlook and credit rating actions
Health insurers overtake hospital stocks: 4 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.